Final Results Of Neomonarch: A Phase 2 Neoadjuvant Study Of Abemaciclib In Postmenopausal Women With Hormone Receptor Positive (Hr+), Her2 Negative Breast Cancer (Bc)

CANCER RESEARCH(2018)

引用 20|浏览24
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要